• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Commercial Metals shares dip slightly after posting Q4 earnings miss

by October 17, 2024
written by October 17, 2024

IRVING, Texas – Commercial Metals Company (NYSE:CMC) reported fourth quarter earnings that fell short of analyst expectations, as macroeconomic uncertainty and weaker sentiment pressured steel product pricing and margins.

Commercial Metals’ shares slipped 0.5% in early trading following the release.

The steel and metal products manufacturer posted net earnings of $103.9 million, or $0.90 per diluted share, for the quarter ended August 31, 2024. This missed the analyst consensus estimate of $0.93 per share. Revenue came in at $2 billion, in line with expectations.

“Though strong by historical standards, our financial results were hampered by weaker sentiment that negatively influenced steel product pricing and margins,” said Peter Matt, President and CEO.

The company’s North America Steel Group saw adjusted EBITDA decrease to $210.9 million from $336.8 million a year ago, driven by lower margins over scrap costs on steel and downstream products.

Looking ahead, Commercial Metals expects consolidated financial results to decline sequentially in the first quarter of fiscal 2025 due to continued macroeconomic uncertainty and dampened sentiment in certain construction industry areas.

“We believe current market conditions represent a transient period of softness created by uncertainty regarding important factors that influence any major capital investment – the cost of funding and future government policy,” Matt added.

The company declared a quarterly dividend of $0.18 per share, representing a 13% YoY increase.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Texas Capital Bancshares beats Q3 expectations, shares rise
next post
Marsh McLennan shares fall as Q3 revenue falls short of estimates

You may also like

Adani, Ambani news units sue OpenAI over copyright,...

March 13, 2026

China’s DeepSeek sets off AI market rout

March 13, 2026

BASF results down on impairments, restructuring

March 13, 2026

Nasdaq futures tumble as China’s AI push rattles...

March 13, 2026

European chipmakers slump as traders gauge DeepSeek AI...

March 13, 2026

Fuji Media, rocked by sexual misconduct allegations, says...

March 13, 2026

China Vanke’s CEO, chairman resign amid growing liquidity...

March 13, 2026

Italy’s MPS shares fall ahead of Mediobanca board...

March 13, 2026

UMG shares rally after new multi-year pact with...

March 13, 2026

British Land stock drops following stake sale

March 13, 2026
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Trump administration alleges Nike discriminated against white workers

      March 13, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      March 13, 2026
    • Retail operator of outdoor sportswear pioneer Eddie Bauer files for bankruptcy

      March 13, 2026
    • Cardi B’s cameo in Bad Bunny’s Super Bowl halftime show leads to dispute on prediction markets

      March 13, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (690)
    • Stock (6,426)

    Latest News

    • Trump administration alleges Nike discriminated against white workers
    • Landmark trial accusing social media companies of addicting children to their platforms begins

    Popular News

    • General Aerospace reports above-consensus Q4 earnings and revenue; stock jumps
    • Pfizer going ‘all in’ on obesity drug development, CEO Bourla says

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy